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The modular adaptor protein ALIX is a key player in
multiple ESCRT-III-mediated membrane remodeling
processes. ALIX is normally present in a closed
conformation due to an intramolecular interaction
that renders ALIX unable to perform its ESCRT func-
tions. Here we demonstrate that M phase-specific
phosphorylation of the intramolecular interaction
site within the proline-rich domain (PRD) of ALIX
transforms cytosolic ALIX from closed to open
conformation. Defining the role of this mechanism
of ALIX regulation in three classical ESCRT-mediated
processes revealed that phosphorylation of the intra-
molecular interaction site in the PRD is required for
ALIX to function in cytokinetic abscission and retro-
viral budding, but not in multivesicular body sorting
of activated epidermal growth factor receptor.
Thus, phosphorylation of the intramolecular interac-
tion site in the PRD is one of the major mechanisms
that activates the ESCRT function of ALIX.
INTRODUCTION
The endosome sorting complexes required for transport
(ESCRT) proteins constitute an evolutionary conserved mem-
brane remodeling system that buds membranes and severs
membrane necks in the opposite topology of endocytosis
(Henne et al., 2011, 2013; Hurley, 2015). The best-character-
ized functions of ESCRT proteins are the multivesicular body
(MVB) sorting of internalized membrane receptors (Babst
et al., 2002a, 2002b; Katzmann et al., 2001), the budding of en-
veloped retroviruses from infected cells (Strack et al., 2003; von
Schwedler et al., 2003), and the membrane scission at the end
of cytokinesis (Carlton and Martin-Serrano, 2007; Morita et al.,
2007). The central event in ESCRT-mediated membrane re-
modeling is the assembly of a highly oligomerized ESCRT-IIIDevelopcomplex from monomeric proteins (McCullough et al., 2015;
Teis et al., 2008), followed by the timely disassembly of this
complex by the ATPase Vps4 (Caillat et al., 2015; Yang et al.,
2015). Upstream of the core event, ALIX (ALG-2 interacting pro-
tein X), in parallel with the ESCRT-I-ESCRT-II complex, binds
both a membrane remodeling cargo and the ESCRT-III compo-
nent CHMP4 to initiate ESCRT-III assembly at the right time
and in the right location (Carlson and Hurley, 2012; Pashkova
et al., 2013).
Structural studies of ALIX revealed that ALIX consists of an
N-terminal banana-shaped Bro1 domain, a middle V letter-
shaped domain, and an intrinsically disordered C-terminal pro-
line-rich domain (PRD) (Fisher et al., 2007). The Bro1 domain
contains a 3D docking site for CHMP4 (hydrophobic Patch 1)
and a linear docking site for Src (hydrophobic Patch 2) (Kim
et al., 2005; McCullough et al., 2008). The V domain contains a
3D hydrophobic pocket around F676 (the F676 pocket), which
is the docking site for retroviral Gag proteins (Lee et al., 2007;
Zhai et al., 2008). The PRD contains two linear docking sites
(717–720 and 852–855) for the ESCRT-I component TSG101
and an ALIX multimerization sequence (Carlton et al., 2008). Us-
ing monoclonal antibodies that recognize different epitopes in
ALIX, we discovered that cytosolic ALIX is normally present in
a closed conformation that is unable to interact with CHMP4,
Src, or viral GAG (Zhou et al., 2008, 2009). This is achieved
through an intramolecular interaction between the Src docking
site in the Bro1 domain and the first TSG101 docking site
(TDS) in the PRD (Zhou et al., 2010). These findings predict
that relieving the intramolecular interaction of ALIX is critical for
multiple ESCRT-III mediated processes.
In MVB sorting of activated epidermal growth factor receptor
(EGFR), calcium-dependent ALG-2 interaction with cytosolic
ALIX relieves its intramolecular interaction and promotes its
association with the membrane through interaction with mem-
brane-bound CHMP4 (Sun et al., 2015b). ALG-2 knockdown
inhibited ALIX-supported MVB sorting and degradation of acti-
vated EGFR, but did not affect ESCRT-mediated cytokinetic
abscission or retroviral budding (Sun et al., 2015a). These find-
ings identify ALG-2 as a critical regulator of ALIX in calcium-
dependent ESCRT processes and predict that a differentmental Cell 36, 331–343, February 8, 2016 ª2016 Elsevier Inc. 331
mechanism activates ALIX for it to function in calcium-indepen-
dent ESCRT-mediated processes.
The Xenopus ortholog of ALIX, Xp95, is phosphorylated both
at the conserved tyrosine residue (Y318) within Patch 2 of the
Bro1 domain (Che et al., 1999) and at multiple sites within the
N-terminal half of the PRD (nPRD) during Xenopus oocyte matu-
ration (Dejournett et al., 2007). Since these phosphorylations
also occur in ALIX (Dejournett et al., 2007; Schmidt et al.,
2005), phosphorylation of one or both of the intramolecular inter-
action sites may transform ALIX from closed to open conforma-
tion. In this study, we demonstrated that mitotic phosphorylation
of cytosolic ALIX at the intramolecular interaction site within the
nPRD transforms ALIX from closed to open conformation. We
also showed that this activating phosphorylation of ALIX is
required for ALIX to function in cytokinetic abscission and equine
infectious anemia virus (EIAV) budding but not in MVB sorting of
activated EGFR.
RESULTS
Cytosolic ALIX Changes from Closed to Open
Conformation during M Phase Induction
As illustrated in Figure 1A, the anti-ALIX antibody 1A3 recognizes
the Patch 2/Src docking site in the Bro1 domain, and the anti-
ALIX antibody 2H12 recognizes the F676 pocket/the viral GAG
docking site in the V domain. Because the intramolecular inter-
action of ALIX renders these two partner protein docking sites
inaccessible, 1A3 and 2H12 only immunoprecipitate opened
ALIX. In contrast, the anti-ALIX antibodies 3A9 and 1A12 recog-
nize conformation-insensitive epitopes within the V domain and
thus immunoprecipitate both opened and closed ALIX (Zhou
et al., 2010). We used immunoprecipitation (IP) with 1A3 or
2H12 to determine whether cytosolic ALIX undergoes a confor-
mational change when HEK293 cells proceed from interphase
(I) to mitosis (M).
Asynchronously growing cells (>95% in I, called I cells) or
mitotically arrested cells (>80% in M, called M cells) were ex-
tracted with a detergent-free buffer to isolate cytosolic proteins
without affecting the intramolecular interaction of ALIX (Zhou
et al., 2008, 2009). ATP and the PP1/PP2A inhibitor microcystin
were added to the extraction buffer for M cells to stabilize the
M phase status of the extracts. Immunoblotting (IB) of I cell
extracts (IE) or M cell extracts (ME) with the mitotic phospho-
protein monoclonal antibody 2 (MPM-2) (Wu et al., 2010)
demonstrated a dramatically increased level of protein phos-
phorylation in M cells. ALIX IB showed that levels of ALIX are
similar between I and M cells (Figure 1B). IP results showed
that 1A12 and 3A9 immunoprecipitated ALIX from both IE
and ME, whereas 1A3 and 2H12 immunoprecipitated ALIX
only from ME (Figure 1C), indicating a conformational change
of ALIX during mitotic entry. To determine whether the differ-
ence in ALIX conformation between IE and ME was due to
different buffer conditions, we prepared both IE and ME in
the presence of ATP and microcystin and performed parallel
IP with 2H12 and 3A9. Under the same buffer conditions,
2H12 immunoprecipitated a trace amount of ALIX from IE but
a high level of ALIX from ME (Figure S1A). The trace amount
of 2H12-immunoprecipitable ALIX in IE could be from a small
percentage of mitotic cells present in I cells. Together, these re-332 Developmental Cell 36, 331–343, February 8, 2016 ª2016 Elsevisults indicate that ALIX changes from closed to open confor-
mation during mitotic entry.
To characterize opened ALIX in M cells, we examined ALIX
interaction with ectopically expressed CHMP4b, endogenous
TSG101, and GST-Src. Both FLAG-CHMP4b and TSG101 coim-
munoprecipitated with ALIX in ME but not in IE (Figures 1D and
1E). GST-Src also specifically pulled down ALIX from ME (Fig-
ure 1F). These results indicate that the opened cytosolic ALIX
in mitotic cells is able to interact with multiple partner proteins.
We previously showed that relieving the intramolecular inter-
action of cytosolic ALIX promotes CHMP4-mediated ALIX asso-
ciation with themembrane in I cells (Sun et al., 2015a; Zhou et al.,
2010). To determine whether this also occurs in M cells, we frac-
tionated the post nuclear supernatant (PNS) of crude cell lysates
from I or M cells by membrane flotation centrifugation. The dis-
tribution of ALIX and CHMP4b between membrane and soluble
protein fractions was similar between I and M cells (Figure S1C),
suggesting that membrane-bound CHMP4 in M cells cannot
interact with newly opened cytosolic ALIX.
To determine whether Xp95 undergoes a conformational
change during oocyte maturation, we immunoprecipitated
Xp95 from interphase-arrested Xenopus oocyte extracts (IOE)
or M phase-arrested Xenopus egg extracts (MEE), which were
also prepared in the absence of detergent, with 1A3 and 1A12.
While 1A12 immunoprecipitated Xp95 from both IOE and MEE,
1A3 specifically immunoprecipitated Xp95 fromMEE (Figure 1G),
indicating that the M phase-associated conformational change
of cytosolic ALIX is a conserved phenomenon that applies to
both mitotic and meiotic cycles.
To determine the role of protein phosphorylation in the confor-
mational change of ALIX during mitotic entry, we treatedMEwith
calf intestinal alkaline phosphatase (CIP) and determined the
effect on ALIX conformation. CIP treatment both eliminated
MPM-2 reactivity (Figure 1H) and reversed 1A3 immunoprecipit-
ability of ALIX (Figures 1I and S1B), indicating that protein phos-
phorylation plays a critical role in the conformational change of
ALIX during mitotic entry. Interestingly, if GST-CHMP4b or
myc-TSG101 was added to ME before the CIP treatment, the
CIP-induced reversal of the 1A3 immunoprecipitability became
partial (Figures 1I and S1B), indicating that the acquired intermo-
lecular interaction of ALIX decreases the probability of reforming
the intramolecular interaction of ALIX after dephosphorylation of
mitotic phosphoproteins.
MEE Treatment of ALIXnPRD Inhibits Its Interaction with
ALIXBro1
To define the protein phosphorylation that relieves the intramo-
lecular interaction of ALIX in mitotic cells, we first incubated
GST-tagged ALIX1-746, which contains both of the intramolecular
interaction sites (Figure 2A) (Zhou et al., 2010), with IOE, MEE, or
MEE plus CIP, and immunoprecipitated the end products with
3A9 or 2H12. 3A9 immunoprecipitated high levels of GST-
ALIX1-746 under all three conditions, whereas 2H12 immunopre-
cipitated a readily detectable level of GST-ALIX1-746 only after its
treatment with MEE (Figure 2B). That the MEE induces an open
conformation of GST-ALIX1-746 was further confirmed by GST-
ALIX1-746 pull-down of FLAG-CHMP4b (Figure 2C).
To identify the ALIX domain through which MEE treatment
relieves the intramolecular interaction of ALIX, we produceder Inc.
Figure 1. Cytosolic ALIX Changes from
Closed to Open Conformation during M
Phase Induction
(A) Schematic illustration of the closed and open
conformations of ALIX.
(B) IB of IE and ME with MPM-2 and 3A9 after
Ponceau S (Ponc) staining.
(C–E) IP of IE and ME with the indicated antibodies,
followed by IB with the indicated antibodies.
(F) Incubation of IE and ME with GST or GST-Src,
followed by IB of bound proteins with the indicated
antibodies.
(G) IB of IOE or MEE with MPM-2, and IP of IOE or
MEE with the indicated antibodies, followed by IB
with 1A3.
(H) IB of IE, ME, and CIP-treated ME with MPM-2.
(I) ME was first incubated with GST or GST-
CHMP4b at 4C for 2 hr and then treated with CIP.
IE, ME, and the two samples of differently treated
ME were immunoprecipitated with the indicated
antibodies, followed by IB with the indicated anti-
bodies. See also Figure S1.GST-ALIXBro1 and myc-ALIXnPRD (Figure 2A) and verified their
interaction. We then incubated the in vitro transcription-linked-
translation (TNT) product of myc-ALIXnPRD with IOE, MEE, or
MEE plus CIP as diagrammed (Figure 2D, left) and determined
the effect onmyc-ALIXnPRD interaction with GST-ALIXBro1. Treat-
ing myc-ALIXnPRD with MEE but not with IOE or MEE plus CIP
induced a gel mobility shift (Figure 2D, middle). Accordingly,
GST-ALIXBro1 pulled down myc-ALIXnPRD treated with IOE or
MEE plus CIP but not with MEE (Figure 2D, right). We also incu-
bated GST-ALIXBro1 with IOE, MEE, or MEE plus CIP, examined
the tyrosine phosphorylation of thewashed substrate, and deter-
mined its interaction with myc-ALIXnPRD. Treating GST-ALIXBro1
with MEE but not with IOE or MEE plus CIP generated immuno-
reactivity to anti-phosphotyrosine antibodies (Figure 2E). How-
ever, the MEE treatment only moderately reduced the ability of
GST-ALIXBro1 to interact with myc-ALIXnPRD (Figure 2F).
Together, these results indicate that the MEE treatment relieves
the intramolecular interaction of ALIX mainly through targeting
the nPRD.Developmental Cell 36, 331–34S718-S721 Phosphorylation Inhibits
the ALIXnPRD Interaction with
ALIXBro1
The nPRD of Xp95 is phosphorylated at
multiple sites in mature oocytes (Dejour-
nett et al., 2007). Sequence alignment of
the nPRD of ALIX with that of Xp95
showed that the nPRD contains seven
conserved S/T residues, two of which
(S718 and S721 in ALIX) localize at or
near the TDS at 717–720 (Figure 3A). We
thus determined whetherMEE phosphory-
lates the S718 and S721 residues in
ALIXnPRD.
The phospho-(Ser/Thr) PKD substrate
antibody #4381 from Cell Signaling Tech-
nology detects peptides containing a
phospho-S/T residue with arginine atthe 3 position and leucine at the 5 position, preferring proline
at the 1 position. Since the S718 context meets all of these
criteria and #4381 preferentially detected a polypeptide about
the size of ALIX in ME (Figure S2A), we used #4381 to determine
whetherMEE phosphorylates the S718 residue in ALIXnPRD.MEE
treatment of the wild-type (WT) but not the S718A-S721A (S2A)
mutant form of GST-ALIXnPRD or myc-ALIXnPRD generated reac-
tivity to #4381, as determined by IB or IP (Figure 3B). We also
generated rabbit polyclonal antibodies against a synthetic ALIX
peptide that is phosphorylated at both S718 and S721 and
observed that the antibodies, named the anti-pS2 antibody
(apS2), also preferentially recognized a polypeptide about the
size of ALIX in ME (Figure S2B). As observed with #4381, apS2
specifically recognized WT but not S2A GST-ALIXnPRD or myc-
ALIXnPRD upon MEE treatment (Figure 3C). The recognition
was sensitive to CIP treatment (Figure S2C). Incubation of WT
but not S2A GST-ALIXnPRD with progesterone-matured oocyte
extracts, freshly prepared in the absence of microcystin, also
generated reactivity to apS2 in a CIP-sensitive manner (Figures3, February 8, 2016 ª2016 Elsevier Inc. 333
Figure 2. MEE Treatment of ALIXnPRD Inhibits Its Interaction with ALIXBro1
(A) Schematic illustration of the regions of ALIX that comprise the three structural domains and the ALIX fragments used in this study.
(B) GST-ALIX1-746 was phosphorylated with IOE, MEE, orMEE plus CIP, and end products were immunoprecipitated with the indicated antibodies, followed by IB
with aGST.
(C) GST or GST-ALIX1-746 was phosphorylated with IOE or MEE, and then absorbed onto GSH beads. The washed beads were used to pull down FLAG-CHMP4b
in IE. IB of input and bound proteins with the indicated antibodies.
(D) Left: experimental flowchart. Middle: IB of input myc-ALIXnPRD; the short line and the asterisk indicate the start and shift positions of myc-ALIXnPRD,
respectively. Right: IB of bound proteins.
(E) Phosphorylation of GST or GST-ALIXBro1 with IOE, MEE, or MEE plus CIP, followed by IB of washed proteins with aphosphotyrosine (p-Tyr).
(F) Washed GST or GST-ALIXBro1 proteins in (E) were tested for interaction with myc-ALIXnPRD by GST pull-down (n = 3 ± SD). **0.001% p < 0.01.S2D–S2F). Collectively, these results indicate that MEE phos-
phorylates S718-S721 in ALIXnPRD.
To determine whether the phosphorylation of ALIXnPRD at
S718-S721 is required for MEE-induced inhibition of the
ALIXnPRD interaction with ALIXBro1, we produced a phosphomi-
metic form of myc-ALIXnPRD on S718-S721 (S718D-S721D,
S2D) and a control phosphodefective form of myc-ALIXnPRD on
S712-S729 (S712A-S729A, S2A). We then incubated S2A,
S2A, or S2D myc-ALIXnPRD with IOE, MEE, or MEE plus CIP,334 Developmental Cell 36, 331–343, February 8, 2016 ª2016 Elseviand characterized their interaction with GST-ALIXBro1. None of
the double mutations eliminated the gel mobility shift of myc-
ALIXnPRD in MEE (Figure 3D, left), consistent with previous re-
sults (Dejournett et al., 2007). However, while S2Amyc-ALIXnPRD
interacted with GST-ALIXBro1 under all three conditions, S2D
myc-ALIXnPRD did not do so under any of the three conditions.
Only S2Amyc-ALIXnPRD interacted with GST-ALIXBro1 upon in-
cubation with IOE or MEE plus CIP but not with MEE (Figure 3D,
right). These results indicate that S718-S721 phosphorylation iser Inc.
Figure 3. S718-S721 Phosphorylation Inhibits the ALIXnPRD Interaction with ALIXBro1
(A) Sequence alignment of the ALIXnPRD with the Xp95 nPRD; the conserved S/T sites are indicated with asterisks.
(B and C) Left: IB of mock-treated or MEE phosphorylated GST-ALIXnPRD with #4381 (B) or apS2 (C). Right: dIP of mock-treated or MEE phosphorylated myc-
ALIXnPRD with #4381 (B) or apS2 (C), followed by IB with amyc.
(D) GST or GST-ALIXBro1 pull-down of the indicated forms of myc-ALIXnPRD after their treatment with IOE, MEE, orMEE plus CIP, followed by IB with the indicated
antibodies.
(E) Pull-down of the indicated forms of myc-ALIXnPRD with GST or GST-ALIXBro1, followed by IB with the indicated antibodies.
(F) GST-ALIXnPRD was mock treated or phosphorylated at 22
C for 1 hr with MEE in the presence or absence of CID755673 (CID), BI-2536 (BI), both inhibitors
(C + B), or staurosporine (ST). After the substrate was immobilized onto GSH beads and washed, bound proteins were probed with apS2 to determine the level of
S718-S721 phosphorylation (n = 3 ± SD). *0.01% p < 0.05; **0.001% p < 0.01; ***p < 0.001.
(G) Phosphorylation of GST-ALIXnPRD with HA-Plx1, followed by IB of the substrate with apS2.required for MEE-induced inhibition of the ALIXnPRD interaction
with ALIXBro1.
S718-S721 phosphorylation may directly inhibit the ALIXnPRD
interaction with ALIXBro1 through phosphorylation-produced
negative charges or by generating a docking site for a cofactor
that prevents the ALIXnPRD interaction with ALIXBro1. To distin-
guish between these two possibilities, we determined the
interaction of different mutant forms of myc-ALIXnPRD with
GST-ALIXBro1 in the absence of Xenopus extracts. GST-ALIXBro1
pulled down WT, S2A, and S2A myc-ALIXnPRD but not
S2D myc-ALIXnPRD (Figure 3E), favoring the direct inhibition
of the ALIXnPRD interaction with ALIXBro1 by S718-S721
phosphorylation.
The S718 context fits with the phosphorylation consensus se-
quences for PKD and PLK1. Since both PKD and PLK1 are acti-
vated in mitotic cells (Golsteyn et al., 1995; Kienzle et al., 2013),
we determined whether PKD and/or PLK1 are the major kinases
in MEE that phosphorylate S718-S721. GST-ALIXnPRD was
phosphorylated with MEE in the presence or absence of the
PKD inhibitor CID755673 and/or the PLK1 inhibitor BI-2536 orDevelopthe pan kinase inhibitor staurosporine, and thewashed substrate
was probed with apS2. The pan kinase inhibitor dramatically in-
hibited the phosphorylation of GST-ALIXnPRD. In contrast, the
PKD and PLK1 inhibitors reduced the phosphorylation to 83%
and 65% of the control level, respectively, and their combined
use reduced the phosphorylation to 59%of the control level (Fig-
ure 3F). We also phosphorylated GST-ALIXnPRD with purified
Xenopus PLK1 (Plx1). WT but not a catalytically inactive (K82R)
Plx1 generated immunoreactivity to apS2 (Figure 3G). These re-
sults indicate that PKD and PLK1 are among the protein kinases
in MEE that phosphorylate S718-S721 in ALIXnPRD.
S718-S721PhosphorylationRelieves the Intramolecular
Interaction of ALIX
We determined the recognition of ALIX from I and M cells by
#4381 and apS2 to establish whether ALIX is phosphorylated
at S718-S721 in M cells. Denatured IE or ME (dIE or dME)
were prepared with 1% SDS to preserve the phosphorylation
status, and denaturing immunoprecipitation (dIP) was performed
after neutralization of SDS with NP-40. Both phosphospecificmental Cell 36, 331–343, February 8, 2016 ª2016 Elsevier Inc. 335
Figure 4. S718-S721 Phosphorylation Relieves the Intramolecular Interaction of ALIX
(A) Left: IB of dIE and dME with MPM-2. Middle: dIP with #4381, followed by IB with 3A9. Right: dIP with 3A9, followed by IB with 3A9 and apS2.
(B) dIP of IE and ME from cells ectopically expressing WT or S2A GFP-ALIX with #4381, followed by IB with aGFP.
(C) dIP of the IE and ME samples in (B) with aGFP, followed by IB with aGFP and apS2.
(D) Left: IB of IE andME from cells ectopically expressing the indicated forms of GFP-ALIXwith the indicated antibodies. Right: IP of the IE orME samples with IgG
or the indicated aALIX, followed by IB with the indicated antibodies.
(E) IP of ME from cells ectopically expressing the indicated forms of GFP-ALIX with IgG or the indicated aALIX, followed by IB of input proteins and
immunocomplexes with aGFP.
(legend continued on next page)
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antibodies differentially recognized ALIX fromMcells (Figure 4A).
When WT or S2A GFP-ALIX was expressed in HEK293 cells,
both #4381 (Figure 4B) and apS2 (Figure 4C) recognized WT
GFP-ALIX but not S2A GFP-ALIX in ME, confirming that the anti-
body recognition was due to S718-S721 phosphorylation.
To determine the effect of S718-S721 phosphorylation on the
intramolecular interaction of ALIX, we ectopically expressedWT,
S2A, S2D, or S2A GFP-ALIX in HEK293 cells and probed their
conformation by IP with 2H12. 2H12 immunoprecipitated WT
and S2A GFP-ALIX from ME but not IE, S2A GFP-ALIX from
neither IE nor ME, but S2D GFP-ALIX from both IE and ME. IB
of the immunocomplexes with aCHMP4b and aTSG101 showed
that, in all cases, the 2H12 immunoprecipitability correlated the
GFP-ALIX interaction with CHMP4b and TSG101 (Figure 4D).
These results indicate that S718-S721 phosphorylation is
responsible for relieving the intramolecular interaction of cyto-
solic ALIX in M cells.
To determine whether phosphorylation of both the S718 and
S721 residues is required for relieving the intramolecular inter-
action of ALIX, we expressed the S718A and S721A single
mutant forms of GFP-ALIX, and probed their conformation in
M cells by IP with 2H12. While 2H12 did not immunoprecipitate
S2A GFP-ALIX, it immunoprecipitated the S718A and S721A
single mutant forms of GFP-ALIX at 40% and 70% of the
level of WT GFP-ALIX, respectively (Figure 4E). These results
indicate that phosphorylation of both the S718 and S721 resi-
dues is required to relieve the intramolecular interaction of
ALIX most efficiently.
The 717–720 motif is also critically involved in ALIX interaction
with TSG101 (Carlton et al., 2008). Since ALIX differentially inter-
acted with TSG101 in mitotic cells (Figure 1E), we speculated
that the phosphorylation of this dual protein interaction site spe-
cifically regulates the intramolecular interaction of ALIX without
affecting ALIX interaction with TSG101. To test this possibility,
we co-expressed FLAG-TSG101 with WT, S2A, or S2D GFP-
ALIX in HEK293 cells and determined the FLAG-TSG101 interac-
tion with each form of GFP-ALIX in IE in the presence of 1%
Triton X-100, which disrupts the intramolecular interaction of
ALIX (Zhou et al., 2008). FLAG-TSG101 interacted with both
mutant forms of GFP-ALIX as efficiently as with WT GFP-ALIX
(Figure 4F), supporting our hypothesis.
To determine the role of PKD and/or PLK1 in S718-S721 phos-
phorylation in M cells, we accumulated cells in mitosis in the
presence or absence of kinase inhibitors and probed ALIX phos-
phorylation with apS2. As anticipated, the pan kinase inhibitor in-
hibited both mitotic entry and S718-S721 phosphorylation. In
contrast, the PKD inhibitor slightly inhibited ALIX phosphoryla-
tion without affecting mitotic entry; the PLK1 inhibitor reduced
ALIX phosphorylation to 75% of the control level without
affecting mitotic entry; and the combined use of the two inhibi-
tors reduced ALIX phosphorylation to 61% of the control level
without affecting mitotic entry (Figure 4G). These results indicate
that PLK1, and likely also PKD, contribute to S718-S721 phos-
phorylation in M cells.(F) IP of IE from cells ectopically coexpressing FLAG-TSG101 and GFP or the in
followed by IB of input proteins and immunocomplexes with the indicated antibo
(G) Left: experimental flowchart for cell treatments. Middle: IB of IE and ME from c
by dIP with 3A9, followed by IB with 3A9 and apS2 (n = 3 ± SD). *0.01% p < 0.0
DevelopS718-S721 Phosphorylation Is Required for ALIX to
Function in Cytokinetic Abscission
Both ALIX and TSG101 interact with cep55 at the midbody
and promote ESCRT-III assembly through recruiting CHMP4
(Carlton and Martin-Serrano, 2007; Morita et al., 2007). Since
the cep55 interaction site in ALIX localizes at 801–806 (Carlton
et al., 2008), which is outside the region required for the
intramolecular interaction of ALIX (Zhou et al., 2010), S718-
S721 phosphorylation is unlikely to be required for ALIX
localization at the midbody but may be required for ALIX to
recruit CHMP4 to the midbody. To test these predictions,
we first examined the effect of ALIX knockdown on the
midbody localization of mCherry (mCh)-tagged CHMP4b or
TSG101 in HeLa cells. Consistent with the current understand-
ing, ALIX knockdown inhibited the midbody localization of
mCh-CHMP4b in >70% of the cells examined but had little ef-
fect on the midbody localization of mCh-TSG101 (Figures S3A
and S3B). We then compared the abilities of different forms of
siRNA-insensitive GFP-ALIX (GFP-ALIX*) to rescue the defect
of the midbody localization of mCh-CHMP4b. All forms of
GFP-ALIX* examined were able to localize at the midbody.
However, while WT and S2A GFP-ALIX* restored the midbody
localization of mCh-CHMP4b to near control levels, S2A GFP-
ALIX* did not (Figure 5A). These results demonstrate that S718-
S721 phosphorylation is required for ALIX to recruit CHMP4 to
the midbody.
The above results predicted that S718-S721 phosphorylation
is required for ALIX to function in cytokinetic abscission. To
test this, we compared the abilities of WT, S2A, and S2A
GFP-ALIX* to rescue the defect of ALIX knockdown cells in
cytokinetic abscission. Consistent with previous observations
(Carlton and Martin-Serrano, 2007; Morita et al., 2007), ALIX
knockdown increased the percentages of midbody-stage and
multinucleated cells from<2% to14%and17%, respectively
(Figure S3C). While the expression of WT or S2A GFP-ALIX*
reduced the percentage of midbody-stage or multinucleated
cells to near control levels, the expression of S2A GFP-ALIX*
did not rescue the cytokinetic abscission defect despite its ability
to localize to the midbody (Figure 5B). The expression of S2A
GFP-ALIX* in control knockdown cells did not generate any phe-
notypes in cytokinetic abscission (data not shown). The intracel-
lular bridge in S2A GFP-ALIX*-expressing cells appeared largely
normal without the secondary ingression. These results sup-
ported our prediction.
Previous studies indicated that 50% of ALIX knockdown
cells had anti-tubulin staining persisting through the Flemming
body, whereas 10% of control cells had such aberrant mid-
bodies (Carlton et al., 2008). Under our experimental conditions,
however, only 3% and 12% of control and ALIX knockdown
cells had aberrant midbodies, respectively (Figure S3D). The
discrepancy of our observation with that in previous studies
could be due to different culture conditions, which may affect
the rate of conversion of midbody-stage cells to multinucleated
cells.dicated forms of GFP-ALIX with aFLAG in the presence of 1% Triton X-100,
dies.
ollected cells with MPM2. Right: determination of S718-S721 phosphorylation
5; **0.001% p < 0.01; ***p < 0.001. See also Figure S2.
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Figure 5. S718-S721 Phosphorylation Is
Required for ALIX to Function in Cytokinetic
Abscission
(A) HeLa cells were transfected with the indicated
agents and cultured as diagrammed, followed by IB
of cell lysates with the indicated antibodies. Fixed
cells were stained with atubulin and aGFP, and
GFP-mCherry double-positive cells were scored for
the midbody localization of mCh-CHMP4b (n = 3 ±
SD). Solid and open arrowheads in the represen-
tative images indicate the presence or absence
of mCh-CHMP4b at the midbody, respectively.
Enlargements (33) depict the midbody area; scale
bar, 50 mm.
(B) HeLa cells were transfected with the indicated
agents and cultured as in (A), followed by IB of cell
lysates with the indicated antibodies. Fixed cells
were stained with atubulin and aGFP, and GFP-
positive cells were scored for midbody stage or
multinucleation (n = 3 ± SD). Solid and open arrows
in representative images indicate GFP-positive
mononucleated and multinucleated cells, respec-
tively; open arrowheads indicate midbodies be-
tween GFP-positive cells; and the asterisks indicate
the midbody localization of GFP-ALIX*.
ns, not significant. ***p < 0.001. Scale bar, 50 mm.
See also Figure S3.S718-S721 Phosphorylation Is Required for ALIX to
Function in EIAV Budding
EIAV budding requires ALIX interaction with both CHMP4b and
the GAG protein p9 (Strack et al., 2003; von Schwedler et al.,
2003). Since relieving the intramolecular interaction of ALIX is
required for both events (Zhou et al., 2010), EIAV budding is an
ideal model system for defining the role of S718-S721 phosphor-
ylation in retroviral budding. GST-p9 pulled down ALIX from ME
but not IE (Figure 6A), indicating that the phosphorylation-
induced open conformation of ALIX supports ALIX interaction
with p9. IP with 1A3 showed that the prior incubation of ME
with GST-p9 partially sustained the open conformation of ALIX
after ME dephosphorylation (Figure 6B). GST-p9 also sustained
the open conformation of GFP-ALIX when GFP-ALIX was first
phosphorylated byMEE and then dephosphorylated by IOE (Fig-
ure S4). These results indicate that the p9 interaction with phos-
phorylated ALIX helps sustain the open conformation of ALIX
after ALIX dephosphorylation.
To determine the role of S718-S721 phosphorylation in
EIAV budding, we first co-expressed WT, S2A, or S2A GFP-
ALIX with an infection-defective EIAV in HEK293 cells and
examined their conformation by IP with 1A3. 1A3 immunopre-
cipitated a readily detectable level of WT or S2A GFP-ALIX
but not S2A GFP-ALIX (Figure 6C), indicating that S718-S721
phosphorylation is required for EIAV-expressing cells to338 Developmental Cell 36, 331–343, February 8, 2016 ª2016 Elsevier Inc.generate a significant pool of opened
ALIX. We then determined the ability of
different forms of GFP-ALIX* to rescue
the defect of ALIX knockdown cells in
EIAV budding. While WT and S2A
GFP-ALIX rescued the defect, S2A GFP-
ALIX did not (Figure 6D), indicating thatS718-S721 phosphorylation is required for ALIX to function in
EIAV budding.
To determine whether S718-S721 phosphorylation that sup-
ports EIAV budding occurs in I or M cells, we determined the
effect of mitotic or S phase arrest on EIAV budding. Arresting
cells in mitosis greatly inhibited EIAV budding (Figure 6E),
whereas arresting cells in S phase had no effect (Figure 6F), indi-
cating that S718-S721 phosphorylation that supports EIAV
budding occurs in interphase cells.
S718-S721 Phosphorylation Does Not Affect the
Function of ALIX in MVB Sorting of Activated EGFR
Our previous studies demonstrated that calcium-dependent
ALG-2 interaction with ALIX relieves the intramolecular interac-
tion of ALIX in EGF-stimulated cells and promotes MVB sorting
of activated EGFR (Sun et al., 2015a). To determine whether
S718-S721 phosphorylation may cooperate with the ALG-2-
dependent mechanism to fully activate the MVB sorting function
of ALIX, we first determined the effect of the S2A mutation on
ALIX association with the membrane, which indicates ALIX inter-
action with membrane-bound CHMP4. ALIX with deletion of the
ALG-2 binding site (DPxY), which inhibits CHMP4-dependent
ALIX association with the membrane, was used as a control
(Sun et al., 2015a). As previously observed, EGF stimulation
increased the membrane-associated WT GFP-ALIX by 3-fold,
Figure 6. S718-S721 Phosphorylation Is Required for ALIX to Function in EIAV Budding
(A) Incubation of GST or GST-p9 with IE or ME, followed by IB of input and bound proteins with the indicated antibodies.
(B) ME was first incubated with GST or GST-p9 at 4C for 2 hr, and then treated with CIP. IE, ME, and the two samples of differently treated ME were immu-
noprecipitated with IgG or 1A3, followed by IB with the indicated antibodies.
(C) Left: experimental flowchart. Middle: IP of cell lysates with the indicated antibodies, followed by IB with aGFP. Right: IB of cell lysates with the indicated
antibodies.
(D–F) HEK293 cells were processed as diagrammed. IB of VLPs and cell lysates with the indicated antibodies. Relative levels of the VLP production were
determined (n = 3 ± SD). ns, not significant. ***p < 0.001. See also Figure S4.and DPxY GFP-ALIX barely associated with the membrane irre-
spective of EGF stimulation. However, S2A GFP-ALIX behaved
similarly as WT GFP-ALIX (Figures 7A and S5A), indicating that
S718-S721 phosphorylation does not affect CHMP4-dependent
ALIX association with the membrane.
We then determined the ability of S2A GFP-ALIX to rescue the
defect of ALIX knockdown cells in MVB sorting of activated
EGFR by the Proteinase K protection assay used in our previous
studies (Sun et al., 2015a, 2015b). Consistent with our previous
results, ALIX knockdown reduced the percentage of protected
EGFR from 60% to 15%. Importantly, both S2A and S2A
GFP-ALIX* rescued the inhibitory effect of ALIX knockdown as
efficiently asWT GFP-ALIX* (Figure 7B, right). These results indi-
cate that S718-S721 phosphorylation does not affect MVB sort-
ing of activated EGFR.DevelopFurthermore, we determined the ability of S2A GFP-ALIX to
rescue the defect of ALIX knockdown cells in the timely
silencing of activated EGFR. As previously observed, ALIX
knockdown prevented the quick and dramatic inactivation of
ERK1/2 after 10 min and sustained the ERK1/2 activation
at 80% and 50% of the peak level at 30 min and 60 min,
respectively. While the effect was rescued by the expression
of WT GFP-ALIX* (Figure 7C), it was not rescued by the expres-
sion of DPxY GFP-ALIX* (Figure S5B). However, S2A GFP-
ALIX* rescued the sustaining effect of ALIX knockdown on
ERK1/2 activation (Figure 7D), indicating that S718-S721 phos-
phorylation does not affect the timely silencing of activated
EGFR.
Finally, we determined the ability of S2A GFP-ALIX to reverse
the retardation of ALIX knockdown cells in EGFR degradationmental Cell 36, 331–343, February 8, 2016 ª2016 Elsevier Inc. 339
Figure 7. S718-S721 Phosphorylation Does Not Affect the Function of ALIX in MVB Sorting of Activated EGFR
(A) HEK293 cells ectopically expressing the indicated forms of GFP-ALIX were mock treated or stimulated with EGF for 1 hr, and the average percentage of each
GFP-ALIX in the M fraction was determined by membrane flotation centrifugation of the PNS (n = 3 ± SD).
(B–F) Left: HEK293 cells were processed as diagrammed, and cell lysates were immunoblotted with the indicated antibodies. Right: cells were stimulated with
EGF for 30min and assayed forMVB sorting of activated EGFR by the Proteinase K protection assay (n = 2 ± data range). (C andD) Cells were stimulated with EGF
for time indicated in minutes, and cell lysates were immunoblotted with the indicated antibodies. The relative levels of p-ERK were determined and normalized
against the level of si-NC cells at 60 min (n = 3 ± SD). (E and F) Cells were stimulated with EGF for the time indicated in hours, and cell lysates were immunoblotted
with the indicated antibodies. The percentages of remaining EGFR at different time points were determined.
ns, not significant. **0.001% p < 0.01; ***p < 0.001. See also Figure S5.under EGF continuous stimulation conditions. Consistent with
our previous results (Sun et al., 2015b), ALIX knockdown
retarded the 50% EGFR degradation from 1 hr to 2 hr, and the
effect was rescued by the expression of WT GFP-ALIX* (Fig-
ure 7E) but not by DPxY GFP-ALIX* (Figure S5C). Importantly,
the expression of S2A GFP-ALIX* rescued the retardation effect340 Developmental Cell 36, 331–343, February 8, 2016 ª2016 Elseviof ALIX knockdown on EGFR degradation (Figure 7F), indicating
that S718-S721 phosphorylation does not affect the timely
degradation of activated EGFR.
Collectively, these results indicate that S718-S721 phosphor-
ylation is not involved in generating opened ALIX that supports
endolysosomal trafficking of activated EGFR.er Inc.
DISCUSSION
Mitosis is a special time in the cell cycle when a great portion of
protein kinases are simultaneously activated (Daub et al., 2008)
and thousands of proteins are robustly phosphorylated (De-
phoure et al., 2008; Olsen et al., 2010). Although none of the
known ESCRT-mediated processes occurs in mitosis, mitotic
cells provide a unique platform to determine the role of protein
phosphorylation in the regulation of ALIX conformation. Using
this platform, we discovered that S718-S721 phosphorylation
transforms ALIX from closed to open conformation and that mul-
tiple protein kinases, including PLK1 and likely also PKD, cata-
lyze S718-S721 phosphorylation. Following this lead, we
demonstrated that S718-S721 phosphorylation is required for
ALIX to function in cytokinetic abscission and EIAV budding,
but does not affect the function of ALIX in MVB sorting of acti-
vated EGFR. These findings identify the phosphorylation of the
intramolecular interaction site within the nPRD as one of the ma-
jor mechanisms that activates the ESCRT function of ALIX.
Since cells undergoing cytokinetic abscission have already
biochemically entered interphase (Gershony et al., 2014), there
seems to be a time lag between the activating phosphorylation
of ALIX and the function of ALIX in cytokinetic abscission. How-
ever, accumulating evidence indicates that multiple activated
mitotic kinases and phosphoproteins remain at the midbody
much longer than the duration of mitosis. For example, the mid-
body was specifically recognized by the mitotic phosphoprotein
monoclonal antibody MPM-2 (Davis et al., 1983; Vandre et al.,
1986), by antibodies that recognize activated MEK, ERK, and
RSK (Willard and Crouch, 2001), by antibodies that recognize
aurora B kinase (Crosio et al., 2002), and by antibodies that
recognize citron kinase and its activator RhoA (Madaule et al.,
1998). #4381 also stained the midbody area after the robust
and widespread mitotic staining disappeared (S.S. and J.K., un-
published data). Therefore, it is possible that some of the mitotic
kinases that catalyze S718-S721 phosphorylation remain active
at the midbody. Once transformed into open conformation by
the activating phosphorylation, the midbody-localized ALIX
recruits CHMP4 and interacts with TSG101. These acquired
intermolecular interactions of ALIX in turn inhibit reformation of
the intramolecular interaction of ALIX even after ALIX dephos-
phorylation. We have yet to identify the ALIX-activating kinases
at the midbody. Although our data indicate that PLK1 is one of
the kinases in mitotic cells that catalyzes the activating phos-
phorylation of ALIX, PLK1 negatively regulates cep55 recruit-
ment to the midbody (Bastos and Barr, 2010), disfavoring this
possibility.
EIAV budding neither occurs inM cells nor requires cells to first
pass through mitosis. Thus, it is somewhat surprising that S718-
S721 phosphorylation is required for ALIX to function in EIAV
budding. For this to occur, one potential scenario is that EIAV
infection induces the activation of a protein kinase that catalyzes
the activating phosphorylation of ALIX. However, when we
probed ALIX phosphorylation in EIAV-expressing cells with the
phosphospecific antibodies, we did not detect positive signals
(S.S. and J.K., unpublished data), suggesting that either EIAV
expression did not induce the activating phosphorylation of
ALIX, or the induction level was too low to be detected. In any
event, it seems improbable that EIAV-expressing cells containDevelopa level of the activating phosphorylation of ALIX that can inde-
pendently explain the ALIX activation required for EIAV budding.
Another potential scenario is that EIAV-expressing cells contain
a low background or induced level of S718-S721 phosphoryla-
tion, which cooperates with a viral factor to generate a significant
pool of activated ALIX. Since EIAV-expressing cells have high
levels of p9 expression, and p9 interaction with phosphorylated
ALIX maintains the open conformation of ALIX after ALIX
dephosphorylation, it is possible that the combined effects of
low levels of ALIX phosphorylation and high levels of p9 expres-
sion generate a significant pool of activated ALIX that supports
EIAV budding.
EGF-induced downregulation of EGFR is a commonly used
model system to study ESCRT-mediated MVB sorting and
lysosome targeting of ubiquitinated membrane receptors in
vertebrate cells. Our previous studies demonstrated that cal-
cium-dependent ALG-2 interaction with ALIX generates opened
ALIX that supports MVB sorting, silencing, and degradation of
activated EGFR (Sun et al., 2015a). Since EGF-induced signal
transduction activates multiple protein kinases, it is possible
that the activating phosphorylation of ALIX cooperates with the
ALG-2 dependent mechanism to maximally activate the MVB
sorting function of ALIX in EGF-stimulated cells. Results in this
study disprove this hypothesis.
MVB sorting of membrane receptors, retroviral budding, and
cytokinetic abscission are three classical ESCRT-mediated
processes that critically involve ALIX function (Bissig and Gruen-
berg, 2014; McCullough et al., 2013). Although ALG-2 expres-
sion is required for ALIX to function in MVB sorting of activated
EGFR, it is not important for ALIX to function in EIAV budding
or cytokinetic abscission (Sun et al., 2015a). These results are
in sharp contrast to the roles of S718-S721 phosphorylation in
the three classical ESCRT-mediated processes. Thus, it seems
that the two identified mechanisms of ALIX activation are inde-
pendently involved in distinct ESCRT-mediated membrane
remodeling processes. Since only ALG-2 interaction with ALIX
requires calcium, it is possible that ALIX activation by ALG-2 is
primarily involved in calcium-dependent ESCRT-mediated
processes, whereas the activating phosphorylation of ALIX is
primarily involved in calcium-independent ESCRT-mediated
processes.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Cell Synchronization
Culture, transfection, and EGF stimulation of HEK293 or HeLa cells were per-
formed as previously described (Sun et al., 2015b). HEK293 cells were syn-
chronized in mitosis through a single thymidine (TdR) (Sigma) block, followed
by nocodazole (NC) (Sigma) block (Wu et al., 2014). HEK293 cells were
arrested in S phase by a single TdR block. The PLK1 inhibitor BI-2536 (Axon
Medchem), PKD inhibitor CID755673 (BioVision), and pan kinase inhibitor
staurosporine (LC Laboratories) were dissolved in DMSO and added to culture
medium to reach a final concentration of 100 nM, 3 mM, and 50 nM, respec-
tively. The siRNAs, mammalian expression vectors, and PCR primers used
in this study are summarized in Tables S1–S3, respectively.
Protein Extraction, Immunoblotting, Immunoprecipitation, and
Immunostaining
Preparation of crude cell lysates for IB were performed as we previously
described (Sun et al., 2015a). Relative signals on immunoblots were quantified
by analyzing scanned images with NIH ImageJ version 1.41o. To preparemental Cell 36, 331–343, February 8, 2016 ª2016 Elsevier Inc. 341
cytosolic proteins for IP or GST pull-down, pelleted cells were sonicated with
10 volumes of extraction buffer (EB), consisting of 80mM b-glycerophosphate,
20 mM EGTA, 15 mMMgCl2, 150 mM NaCl, 1 mM DTT, and proteinase inhib-
itor cocktail (Sigma) (pH 7.4). For extraction of M cells and occasionally also I
cells, EB was freshly supplemented with 1 mM microcystin (Sigma) and 1 mM
ATP. Cell lysates were cleared by centrifugation at 16,000 g for 10 min at 4C.
CIP (New England Biolabs) was added to ME/MEE at a final concentration of
1 unit/mg substrate proteins. Samples were immunoprecipitated with the indi-
cated antibodies, and immunocomplexes were washed five times with EB. To
prepare cell lysates for dIP, pelleted cells were re-suspended with 10 volumes
of denaturing buffer consisting of 50mMTris-HCl (pH 7.5), 1%SDS, and 5mM
DTT, and sonicated. After the samples were boiled for 5 min and cleared by
centrifugation at 16,000 g for 5 min, they were diluted 10-fold with an SDS-
neutralizing IP buffer consisting of 50 mM Tris-HCl (pH 7.5), 250 mM NaCl,
5 mM EDTA, 0.5% NP-40, 1 mM DTT (Tansey, 2007), and proteinase inhibitor
cocktail (Sigma). Samples were immunoprecipitated with the indicated anti-
bodies, and immunocomplexes were washed five times with the IP buffer.
Production of apS2 and immunostaining are described in Supplemental
Experimental Procedures.
In Vitro Phosphorylation of ALIX Fragments with Xenopus Extracts
and GST Pull-Down
MEE and IOE were prepared as previously described (Wu et al., 2010). In vitro
transcription and linked translation was performed by using the TNT Quick
Coupled Transcription/Translation System (Promega). GST and GST-tagged
proteins were produced and purified using our standard procedures (Che
et al., 1997). The phosphorylation reaction included one volume of substrate
proteins and three volumes of IOE or MEE. The reaction was performed at
22C for 2 hr unless otherwise indicated, and terminated by adding SDS-
PAGE sample buffer. BI-2536, CID755673, and staurosporine were added to
MEE at 4C 15 min prior to the phosphorylation reaction to reach a final con-
centration of 2 mM, 5 mM, and 5 mM, respectively. GST-tagged proteins were
absorbed onto glutathione (GSH) beads (GenScript) at 4C for 2 hr. After
GSH beads were washed five times with EB, proteins remaining on the beads
were eluted with SDS-PAGE sample buffer for IB.
EIAV VLP Release Assay, Membrane Flotation Centrifugation, and
Proteinase K Protection Assay
Assays of virus-like particle (VLP) release from HEK293 cells transfected with
the pEV53B EIAVGag vector, fractionation of the PNS of crude lysates of
HEK293 cells by membrane flotation centrifugation, and measurement of
MVB sorting of activated EGFR by the Proteinase K protection assay were per-
formed exactly as we previously described (Sun et al., 2015b).
Statistical Analysis
Statistical analyses were performed using Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2016.01.001.
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